Healing Light Therapy
for Cellular Health
This is a testimonial video of a young woman going through years of issues in her gut without any help from normal testing and doctor visits. Frankly, we at beytOMR can relate to her story all to well. Thanks to Firefly treatments in many different frequencies on our own gut issues, our insides are MUCH better!
Roger Seheult, MD of MedCram examines an exciting randomized control trial demonstrating the effects of near infrared light on COVID-19.
Photobiomodulation and methylene blue are neuroprotective. These interventions not only reduce cellular apoptosis, but also improve the tissue healing by improving the blood flow to the tissues. Let’s review how photobiomodulation works to help mitochondria heal and function correctly.
Huberman Lab describes the mechanisms by which different wavelengths of light impact the cells, tissues and organs of the human body, and how specifically timed light exposure of specific wavelengths can be used to improve sleep, enhance alertness, modulate hormone levels, and improve mood.
Low-level light therapy (LLLT) is a recent addition to the pantheon of light-based therapeutic interventions. The absorption of red/near-infrared light energy, a process termed “photobiomodulation,” enhances mitochondrial ATP production, cell signaling, and growth factor synthesis, and attenuates oxidative stress.
Patient Linda was diagnosed with stage 3 cancer. Her doctor told her that her neuropathy would worsen and won’t be able to walk again. She met with Leigh Erin Connealy, MD and she recommended that she see Martin Bales, LAc DAOM for her neuropathy. After a couple of Firefly treatments from Dr. Bales, she can feel her feet again.
Laser photobiomodulation is more effective than ultrasound therapy in patients with chronic nonspecific low back pain
The purpose of this study was to compare the effects of laser photobiomodulation therapy (lPBMt) and ultrasound therapy (UST) in patients with chronic non-specific low back pain (CNLBP). Forty-five patients with CNLBP aged 30-40 years were divided randomly into three groups of 15 subjects each.